Search research articles
Contact Us
Filters
Showing results (61-70 of 109) with videos related to
Page
of 11
Sort By:
Thrombosis and Haemostasis
|
December 22, 1999
Regulation of the thrombotic potential of atheroma
P Libby, F Mach, U Schönbeck, et al.
Revue Medicale Suisse
|
April 18, 2006
[Erectile dysfunction: a potential useful marker for cardiovascular disease]
L Sekoranja, F Bianchi-Demicheli, J M Gaspoz, et al.
Revue Medicale Suisse
|
May 15, 2008
[Heart failure and sexual dysfunction]
L Sekoranja, F Bianchi-Demicheli, J M Gaspoz, et al.
Thrombosis and Haemostasis
|
March 1, 2013
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases
F Carbone, A Nencioni, F Mach, et al.
Swiss Medical Weekly
|
February 24, 2001
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells
B Kwak, F Mulhaupt, N Veillard, et al.
Thrombosis and Haemostasis
|
August 23, 2013
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome
F Carbone, F Montecucco, F Mach, et al.
Nature
|
July 22, 1998
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
F Mach, U Schönbeck, G K Sukhova, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
K Shimizu, U Schönbeck, F Mach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2000
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
U Schönbeck, G K Sukhova, K Shimizu, et al.
The American Journal of Medicine
|
April 29, 1998
Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization
P Libby, U Schoenbeck, F Mach, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 109) with videos related to
Sort By:
Page
of 11
Thrombosis and Haemostasis
|
December 22, 1999
Regulation of the thrombotic potential of atheroma
P Libby, F Mach, U Schönbeck, et al.
Revue Medicale Suisse
|
April 18, 2006
[Erectile dysfunction: a potential useful marker for cardiovascular disease]
L Sekoranja, F Bianchi-Demicheli, J M Gaspoz, et al.
Revue Medicale Suisse
|
May 15, 2008
[Heart failure and sexual dysfunction]
L Sekoranja, F Bianchi-Demicheli, J M Gaspoz, et al.
Thrombosis and Haemostasis
|
March 1, 2013
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases
F Carbone, A Nencioni, F Mach, et al.
Swiss Medical Weekly
|
February 24, 2001
The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells
B Kwak, F Mulhaupt, N Veillard, et al.
Thrombosis and Haemostasis
|
August 23, 2013
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome
F Carbone, F Montecucco, F Mach, et al.
Nature
|
July 22, 1998
Reduction of atherosclerosis in mice by inhibition of CD40 signalling
F Mach, U Schönbeck, G K Sukhova, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis
K Shimizu, U Schönbeck, F Mach, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2000
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice
U Schönbeck, G K Sukhova, K Shimizu, et al.
The American Journal of Medicine
|
April 29, 1998
Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization
P Libby, U Schoenbeck, F Mach, et al.
Page
of 11